PRELUDE CAPITAL MANAGEMENT, LLC - CASTLE BIOSCIENCES INC ownership

CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 159 filers reported holding CASTLE BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CASTLE BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$525,832
-3.5%
23,1440.0%0.03%
+10.7%
Q4 2022$544,810
-9.8%
23,1440.0%0.03%
+27.3%
Q3 2022$604,000
+19.4%
23,144
+0.4%
0.02%
+57.1%
Q2 2022$506,000
+51.0%
23,058
+208.8%
0.01%
+40.0%
Q1 2022$335,000
+33.5%
7,467
+27.5%
0.01%
+66.7%
Q4 2021$251,000
-26.6%
5,855
+13.7%
0.01%
-33.3%
Q3 2021$342,000
-9.3%
5,148
+0.1%
0.01%
-18.2%
Q2 2021$377,000
-54.5%
5,143
-78.7%
0.01%
-64.5%
Q4 2019$828,000
+89.9%
24,1010.0%0.03%
+55.0%
Q3 2019$436,00024,1010.02%
Other shareholders
CASTLE BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 33,626$567,94377.21%
Millrace Asset Group, Inc. 77,315$1,3061.61%
Granahan Investment Management 2,487,673$42,016,7971.50%
Parkman Healthcare Partners LLC 224,592$3,793,3590.70%
PERKINS CAPITAL MANAGEMENT INC 29,160$4930.49%
Capital Impact Advisors, LLC 16,554$279,5970.47%
Soleus Capital Management, L.P. 283,500$4,788,3150.44%
Portolan Capital Management 253,028$4,273,6430.40%
Numerai GP LLC 68,163$1,151,2730.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 946,620$15,988,4120.35%
View complete list of CASTLE BIOSCIENCES INC shareholders